Biofrontera (BFRIW) Other Non-Current Assets (2020 - 2025)

Biofrontera (BFRIW) recorded quarterly Other Non-Current Assets of $360000.0 in Q4 2025, down 23.73% quarter-over-quarter from $472000.0 in Q3 2025, and down 6.01% on a YoY basis from $383000.0 in Q4 2024.

Biofrontera (BFRIW) Other Non-Current Assets (2020 - 2025) Analysis & Trends

Biofrontera's Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $360000.0 for Q4 2025.

  • In Q4 2025, Other Non-Current Assets fell 6.01% year-over-year to $360000.0; the TTM figure through Dec 2025 stood at $360000.0 (down 6.01% YoY), while the FY2025 annual figure was $360000.0, down 6.01% from the prior year.
  • Other Non-Current Assets was $360000.0 for Q4 2025 at Biofrontera, down from $472000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.4 million in Q3 2021 to a low of $85000.0 in Q3 2022.
  • Historically, Other Non-Current Assets has averaged $418411.8 across 5 years, with a median of $383000.0 in 2024.
  • The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets tumbled 93.81% in 2022, then surged 478.82% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $268000.0 in 2021, then gained by 19.4% to $320000.0 in 2022, then soared by 50.62% to $482000.0 in 2023, then fell by 20.54% to $383000.0 in 2024, then fell by 6.01% to $360000.0 in 2025.
  • The last three Other Non-Current Assets figures came in at $360000.0 (Q4 2025), $472000.0 (Q3 2025), and $535000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.79 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 351.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 233.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 3.45 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 73.60 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 295.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 59.36 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 47.63 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Biofrontera - - 14.09 Mn 360,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 360,000.00
Sep 30, 2025 472,000.00
Jun 30, 2025 535,000.00
Mar 31, 2025 453,000.00
Dec 31, 2024 383,000.00
Sep 30, 2024 383,000.00
Jun 30, 2024 324,000.00
Mar 31, 2024 328,000.00
Dec 31, 2023 482,000.00
Sep 30, 2023 492,000.00
Mar 31, 2023 384,000.00
Dec 31, 2022 320,000.00
Sep 30, 2022 85,000.00
Jun 30, 2022 343,000.00
Mar 31, 2022 128,000.00
Dec 31, 2021 268,000.00
Sep 30, 2021 1.37 Mn
Dec 31, 2020 121,000.00